Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells

被引:103
作者
Reynolds, Paul A.
Sigaroudinia, Mahvash
Zardo, Giuseppe
Wilson, Matthew B.
Benton, Geoffrey M.
Miller, Caroline J.
Hong, Chibo
Fridlyand, Jane
Costello, Joseph F.
Tlsty, Thea D.
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M604175200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alterations in DNA methylation are important in cancer, but the acquisition of these alterations is poorly understood. Using an unbiased global screen for CpG island methylation events, we have identified a non-random pattern of DNA hypermethylation acquired in p16-repressed cells. Interestingly, this pattern included loci located upstream of a number of homeobox genes. Upon removal of p16(INK4A) activity in primary human mammary epithelial cells, polycomb repressors, EZH2 and SUZ12, are upregulated and recruited to HOXA9, a locus expressed during normal breast development and epigenetically silenced in breast cancer. We demonstrate that at this targeted locus, the up-regulation of polycomb repressors is accompanied by the recruitment of DNA methyltransferases and the hypermethylation of DNA, an endpoint, which we show to be dependent on SUZ12 expression. These results demonstrate a causal role of p16INK4A disruption in modulating DNA hypermethylation, and identify a dynamic and active process whereby epigenetic modulation of gene expression is activated as an early event in breast tumor progression.
引用
收藏
页码:24790 / 24802
页数:13
相关论文
共 58 条
[31]  
Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807, DOI 10.1080/10618600.1996.10474713]
[32]   The fundamental role of epigenetic events in cancer [J].
Jones, PA ;
Baylin, SB .
NATURE REVIEWS GENETICS, 2002, 3 (06) :415-428
[33]   Genomic structure and sequence analysis of human HOXA-9 [J].
Kim, MH ;
Chang, HH ;
Shin, C ;
Cho, MS ;
Park, D ;
Park, HW .
DNA AND CELL BIOLOGY, 1998, 17 (05) :407-414
[34]  
Kirmizis A, 2003, MOL CANCER THER, V2, P113
[35]   EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells [J].
Kleer, CG ;
Cao, Q ;
Varambally, S ;
Shen, RL ;
Ota, L ;
Tomlins, SA ;
Ghosh, D ;
Sewalt, RGAB ;
Otte, AP ;
Hayes, DF ;
Sabel, MS ;
Livant, D ;
Weiss, SJ ;
Rubin, MA ;
Chinnaiyan, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11606-11611
[36]   Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation [J].
Kuzmichev, A ;
Margueron, R ;
Vaquero, A ;
Preissner, TS ;
Scher, M ;
Kirmizis, A ;
Ougang, XS ;
Brockdorff, N ;
Abate-Shen, C ;
Farnham, P ;
Reinberg, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :1859-1864
[37]   Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer [J].
Leu, YW ;
Yan, PS ;
Fan, MY ;
Jin, VX ;
Liu, JC ;
Curran, EM ;
Welshons, WV ;
Wei, SH ;
Davuluri, RV ;
Plass, C ;
Nephew, KP ;
Huang, THM .
CANCER RESEARCH, 2004, 64 (22) :8184-8192
[38]   MethPrimer: designing primers for methylation PCRs [J].
Li, LC ;
Dahiya, R .
BIOINFORMATICS, 2002, 18 (11) :1427-1431
[39]   p16INK4a prevents centrosome dysfunction and genomic instability in primary cells [J].
McDermott, KM ;
Zhang, JM ;
Holst, CR ;
Kozakiewicz, BK ;
Singla, V ;
Tlsty, TD .
PLOS BIOLOGY, 2006, 4 (03) :350-365
[40]  
Meluh PB, 1999, METHOD ENZYMOL, V304, P414